Life Sciences Tools and Services
Company Overview of Quintiles Transnational Corp.
Quintiles Transnational Corp. provides contract research, clinical trial, and pharmaceutical consulting services. It offers advisory services in the areas of asset evaluation and due diligence, integrated asset development plan, clinical transformation strategies, regulatory and safety virtualization, value and outcomes evidence optimization, launch of the future, mature product and outsourcing strategies, end-to-end partnerships, and quality and compliance; and portfolio and strategy planning services in the areas of biosimilars, clinical trial planning and design, generics clinical development, and model-based drug development. The company also provides clinical trial execution services in...
4820 Emperor Boulevard
Durham, NC 27703-8411
Founded in 1990
Key Executives for Quintiles Transnational Corp.
President and Head of Asia Pacific
Executive Chairman and Member of Executive Committee
Compensation as of Fiscal Year 2016.
Quintiles Transnational Corp. Key Developments
Quintiles to Invest $2.4 Million in Bulgarian Clinical Research Center in Sofia
Dec 23 15
Quintiles announced that it plans to invest $2.4 million in the expansion of a clinical research center in Sofia. After the investment, the Bulgarian unit of the company will be able to remotely process data from clinical trials, the company reported. Quintiles plans to hire 436 for the new project.
Quintiles to Invest €2.2 Million in Bulgarian Clinical Center
Dec 23 15
Quintiles plans to invest BGN 4.3 million ($2.4 million/€2.2 million) in the expansion of a clinical research center in Sofia. After the investment, the Bulgarian unit of the company will be able to remotely process data from clinical trials. Quintiles plans to hire 436 for the new project.
Quintiles Transnational Corp. Announces Pricing of $800 Million Senior Notes Offering
May 6 15
Quintiles Transnational Holdings Inc. announced that Quintiles Transnational Corp., its subsidiary, has priced $800 million principal amount of 4.875% senior unsecured notes due 2023 offered in a private placement that is exempt from the registration requirements of the Securities Act of 1933, as amended. The company intends to use the net proceeds of the offering, together with proceeds from its previously announced proposed senior secured credit facility, which is expected to increase to a total of $1.95 billion, including $1.45 billion of term loans, to refinance its existing credit facility, as well as for general corporate purposes, including corporate transactions and equity repurchases. The Senior Notes will be fully and unconditionally guaranteed on an unsecured basis by Quintiles Transnational’s domestic subsidiaries that guarantee the senior secured credit facility. The issuance of the Senior Notes is expected to occur on or about May 12, 2015, concurrently with the expected closing of the new senior secured credit facility, subject to customary closing conditions. The Senior Notes are being offered in the United States only to qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|